Bleomycin-induced Pneumonitis in a Child Treated With Nintedanib: Report of the First Case in a Childhood

被引:2
|
作者
Gundogan, Begumhan D. [1 ]
Taskinlar, Simge [4 ]
Arikoglu, Tuba [2 ]
Balci, Yuksel [3 ]
Citak, Elvan C. [1 ]
机构
[1] Mersin Univ, Fac Med, Dept Pediat Oncol, TR-33110 Mersin, Turkey
[2] Mersin Univ, Fac Med, Dept Pediat Allergy & Immunol, Mersin, Turkey
[3] Mersin Univ, Fac Med, Dept Radiol, Mersin, Turkey
[4] Mersin City Hosp, Dept Pediat Hematol & Oncol, Mersin, Turkey
关键词
nindetanib; bleomycin-induced pneumonia; children; pulmonary fibrosis; PULMONARY TOXICITY; CANCER; MODELS;
D O I
10.1097/MPH.0000000000002266
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pulmonary fibrosis caused by bleomycin-induced pneumonia (BIP) is the most important side effect limiting the use of bleomycin and is mainly treated with corticosteroids. However, 1% to 4% of patients do not respond to corticosteroid therapy. Idiopathic pulmonary fibrosis and BIP develop by similar pathophysiological mechanisms. Nintedanib is a tyrosine kinase inhibitor used successfully in the treatment of idiopathic pulmonary fibrosis and there is no information about its use in BIP treatment. Here, we would like to present a 13-year-old boy with Hodgkin lymphoma who developed BIP after 2 cycles of ABVD (Adriamycin, bleomycin, vinblastine, and dacarbazine) and 4 cycles of BAECOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone), whose respiratory failure impaired despite corticosteroid therapy, but was successfully treated with nintedanib.
引用
收藏
页码:E500 / E502
页数:3
相关论文
共 50 条
  • [21] Azacitidine-Induced Pneumonitis in a Patient with Myelodysplastic Syndrome: First Case Report in Japan
    Hayashi, Makoto
    Takayasu, Hiromi
    Tada, Mami
    Yamazaki, Yohei
    Tateno, Hidetsugu
    Tazawa, Sakiko
    Wakabayashi, Aya
    Iwasaki, Takuya
    Tsuchiya, Yutaka
    Yamashita, Jun
    Takeda, Norikazu
    Tomita, Shogo
    Mori, Hiraku
    Kokubu, Fumio
    INTERNAL MEDICINE, 2012, 51 (17) : 2411 - 2415
  • [22] Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway
    Li, Li-Fu
    Kao, Kuo-Chin
    Liu, Yung-Yang
    Lin, Chang-Wei
    Chen, Ning-Hung
    Lee, Chung-Shu
    Wang, Chih-Wei
    Yang, Cheng-Ta
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (11) : 2937 - 2949
  • [23] Paclitaxel-Induced Pneumonitis in Trinidad: A Case Report
    Mohan, Nishtha
    Dalip, Dominic
    Rampersad, Fidel S.
    Jaggernauth, Shiva
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [24] Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice
    Lin Pan
    Yiju Cheng
    Wenting Yang
    Xiao Wu
    Honglan Zhu
    Meigui Hu
    Yuquan Zhang
    Menglin Zhang
    Inflammation, 2023, 46 : 1531 - 1542
  • [25] Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice
    Pan, Lin
    Cheng, Yiju
    Yang, Wenting
    Wu, Xiao
    Zhu, Honglan
    Hu, Meigui
    Zhang, Yuquan
    Zhang, Menglin
    INFLAMMATION, 2023, 46 (04) : 1531 - 1542
  • [26] FIRST CASE REPORT OF BRUCELLOSIS IN A CHILD IN THAILAND
    Lapphra, Keswadee
    Leelaporn, Amornrut
    Vanprapar, Nirun
    Chearskul, Pimpanada
    Sawawiboon, Naphatsara
    Wittawatmongkol, Orasri
    Chokephaibulkit, Kulkanya
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2014, 45 (04) : 890 - 896
  • [27] Hydroxyurea-induced interstitial pneumonitis: case report and review of the literature
    Internullo, M.
    Giannelli, V. V.
    Sardo, L.
    Antonaglia, C.
    Villani, T.
    Angelici, E.
    Palange, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (02) : 190 - 193
  • [28] Radiation Recall Pneumonitis Induced by Sintilimab: A Case Report and Literature Review
    Wang, Min
    Xu, Shuhui
    Zhu, Hui
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] Refractory relapsing polychondritis in a child treated with antiCD20 monoclonal antibody (rituximab): First case report
    Abdwani, Reem
    Kolethekkat, Arif Ali
    Al Abri, Rashid
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2012, 76 (07) : 1061 - 1064
  • [30] Recurrent glioblastoma of childhood treated with bevacizumab: case report and molecular features
    Zhang, Wei
    Lin, Yi
    Chen, Baoshi
    Song, Sonya Wei
    Jiang, Tao
    CHILDS NERVOUS SYSTEM, 2010, 26 (01) : 137 - 143